| Autor: |
Flohr C; Department of Paediatric Dermatology, St John's Institute of Dermatology, King's College London and Guy's and St Thomas' NHS Foundation Trust, London, UK., Irvine AD; Clinical Medicine, Trinity College, Dublin, Ireland., Cork MJ; Department of Infection, Immunity & Cardiovascular Disease, Sheffield Dermatology Research, University of Sheffield, Sheffield, UK.; Sheffield Children's Hospital, Sheffield, UK., Simpson EL; Department of Dermatology, Oregon Health and Science University, Portland, OR, USA., Wollenberg A; Department of Dermatology and Allergy, Ludwig-Maximilian University, Munich, Germany.; Department of Dermatology, Free University Brussels, University Hospital, Brussels, Belgium., Deleuran M; Aarhus University Hospital, Aarhus, Denmark., Praestgaard A; Sanofi, Cambridge, MA, USA., Thomas RB; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Rossi AB; Sanofi, Cambridge, MA, USA. |
